{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:10:00Z","timestamp":1777590600952,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B06028086"],"award-info":[{"award-number":["NRF-2017R1D1A1B06028086"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.parkreldis.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T03:13:46Z","timestamp":1550114026000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-6265","authenticated-orcid":false,"given":"Yoon-Sang","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-7977","authenticated-orcid":false,"given":"Joong-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eo-Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2231-672X","authenticated-orcid":false,"given":"Chul Hyoung","family":"Lyoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.02.012_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","article-title":"Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies","volume":"82","author":"Kaasinen","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jns.2018.05.006","article-title":"Can early dopamine transporter imaging serve as a predictor of Parkinson's disease progression and late motor complications?","volume":"390","author":"Djaldetti","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.parkreldis.2018.05.008","article-title":"Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off","volume":"53","author":"Chung","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","article-title":"123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies","volume":"30","author":"Orimo","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib7","article-title":"Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease","author":"Brandl","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.74.4.423","article-title":"Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease","volume":"74","author":"Hamada","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.21499","article-title":"Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease","volume":"22","author":"Spiegel","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/jnnp-2015-310327","article-title":"Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease","volume":"86","author":"Tsujikawa","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1468-1331.2010.03211.x","article-title":"Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"18","author":"Watanabe","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000002424","article-title":"Initial versus follow-up sequential myocardial 123I-MIBG scintigraphy to discriminate Parkinson disease from atypical parkinsonian syndromes","author":"Ryu","year":"2019","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/ene.13206","article-title":"Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?","volume":"24","author":"Kim","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib14","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2967\/jnumed.118.208686","article-title":"Cardiac sympathetic denervation can predict the wearing-off phenomenon in patients with Parkinson's disease","volume":"59","author":"Lee","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00259-008-0976-x","article-title":"How to use myocardial 123I-MIBG scintigraphy in chronic heart failure","volume":"36","author":"Agostini","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14802\/jmd.15015","article-title":"123)I-metaiodobenzylguanidine myocardial scintigraphy in Lewy body-related disorders: a literature review","volume":"8","author":"Chung","year":"2015","journal-title":"J Mov Disord"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib21","article-title":"Feasibility of computed tomography-guided methods for spatial normalization of dopamine transporter positron emission tomography image","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00006231-199405000-00003","article-title":"Decreased 123I-MIBG uptake and increased clearance in various cardiac diseases","volume":"15","author":"Nakajima","year":"1994","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2017.01.042","article-title":"Combined use of dopamine transporter imaging (DAT-SPECT) and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease","volume":"375","author":"Yoshii","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12149-013-0702-z","article-title":"Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease","volume":"27","author":"Chiaravalloti","year":"2013","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2018.02.039","article-title":"Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis","volume":"51","author":"Lee","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/01.wnl.0000285082.18969.3a","article-title":"Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation","volume":"70","author":"Rajput","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00702-017-1692-0","article-title":"Parkinson's disease as a multisystem disorder","volume":"124","author":"Klingelhoefer","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2019.02.012_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","article-title":"Targeting the norepinephrinergic system in Parkinson's disease and related disorders: the locus coeruleus story","volume":"102","author":"Vermeiren","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging","volume":"34","author":"Kalaitzakis","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2019.02.012_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","article-title":"The threshold theory for Parkinson's disease","volume":"40","author":"Engelender","year":"2017","journal-title":"Trends Neurosci."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019300586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019300586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:15:53Z","timestamp":1761178553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019300586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":32,"alternative-id":["S1353802019300586"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.012","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}